Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Rotigotine: a novel dopamine agonist for the transdermal treatment of Parkinson's disease.

Zareba G.

Drugs Today (Barc). 2006 Jan;42(1):21-8. Review.

PMID:
16511608
2.

Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome.

Boroojerdi B, Wolff HM, Braun M, Scheller DK.

Drugs Today (Barc). 2010 Jul;46(7):483-505. doi: 10.1358/dot.2010.46.7.1463530. Review.

PMID:
20683503
3.

An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.

Elshoff JP, Cawello W, Andreas JO, Mathy FX, Braun M.

Drugs. 2015 Apr;75(5):487-501. doi: 10.1007/s40265-015-0377-y. Review.

4.

Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.

Splinter MY.

Ann Pharmacother. 2007 Feb;41(2):285-95. Epub 2007 Jan 9. Review.

PMID:
17213296
5.

Transdermal rotigotine: a clinically innovative dopamine-receptor agonist for the management of Parkinson's disease.

Chen JJ, Swope DM, Dashtipour K, Lyons KE.

Pharmacotherapy. 2009 Dec;29(12):1452-67. doi: 10.1592/phco.29.12.1452. Review.

PMID:
19947805
6.

Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome.

Kenney C, Jankovic J.

Expert Opin Pharmacother. 2007 Jun;8(9):1329-35. Review. Erratum in: Expert Opin Pharmacother. 2007 Oct;8(14):2447-8.

PMID:
17563266
7.

From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.

Bogan RK.

Clin Ther. 2014 Mar 1;36(3):436-55. doi: 10.1016/j.clinthera.2014.01.021. Review.

8.

Rotigotine transdermal patch for the treatment of Parkinson's Disease.

Perez-Lloret S, Rey MV, Ratti PL, Rascol O.

Fundam Clin Pharmacol. 2013 Feb;27(1):81-95. doi: 10.1111/j.1472-8206.2012.01028.x. Epub 2012 Feb 9. Review.

PMID:
22320451
9.

Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.

Benitez A, Edens H, Fishman J, Moran K, Asgharnejad M.

Ann N Y Acad Sci. 2014 Nov;1329:45-66. doi: 10.1111/nyas.12508. Epub 2014 Aug 21. Review.

PMID:
25145951
10.

Rotigotine transdermal delivery for the treatment of restless legs syndrome.

Sixel-Döring F, Trenkwalder C.

Expert Opin Pharmacother. 2010 Mar;11(4):649-56. doi: 10.1517/14656561003621257. Review.

PMID:
20163275
11.

Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease.

Sanford M, Scott LJ.

CNS Drugs. 2011 Aug;25(8):699-719. doi: 10.2165/11206750-000000000-00000. Review.

PMID:
21790211
12.

Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome.

Garnock-Jones KP.

Drugs. 2016 Jul;76(10):1031-40. doi: 10.1007/s40265-016-0601-4. Review.

PMID:
27324269
13.

Transdermal rotigotine (Neupro) for Parkinson's disease.

[No authors listed]

Med Lett Drugs Ther. 2007 Aug 27;49(1268):69-70. No abstract available.

PMID:
17712291
14.

Rotigotine for restless legs syndrome.

Davies S.

Drugs Today (Barc). 2009 Sep;45(9):663-8. doi: 1396674/dot.2009.45.9.1399952.

PMID:
19956807
15.

Transdermal rotigotine: a new non-ergot dopamine agonist for the treatment of Parkinson's disease.

Naidu Y, Chaudhuri KR.

Expert Opin Drug Deliv. 2007 Mar;4(2):111-8. Review.

PMID:
17335409
16.

Rotigotine: the first new chemical entity for transdermal drug delivery.

McAfee DA, Hadgraft J, Lane ME.

Eur J Pharm Biopharm. 2014 Nov;88(3):586-93. doi: 10.1016/j.ejpb.2014.08.007. Epub 2014 Aug 27. Review.

PMID:
25173087
17.

Spotlight on rotigotine in Parkinson's disease.

Baldwin CM, Keating GM.

Drugs Aging. 2008;25(2):175-7.

PMID:
18257604
18.

Rotigotine transdermal patch: a review of its use in the management of Parkinson's disease.

Baldwin CM, Keating GM.

CNS Drugs. 2007;21(12):1039-55. Review.

PMID:
18020483
19.

Clinical pharmacology and efficacy of rotigotine (Neupro® patch) in the treatment of restless leg syndrome.

Ferini-Strambi L, Marelli S, Galbiati A.

Expert Opin Drug Metab Toxicol. 2016 Aug;12(8):967-75. doi: 10.1080/17425255.2016.1194393. Epub 2016 Jun 16. Review.

PMID:
27224246
20.

Rotigotine: Parkinson's disease: a step backward.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):60.

PMID:
18516813

Supplemental Content

Support Center